CA
NZ
UK
AU
IND
US
GE Aerospace (NYSE:GE) opened fiscal 2026 with results that would have been difficult to fault under normal operating conditions. Against a backdrop of war in the Middle East, elevated jet fuel prices, and softening global GDP forecasts, the company delivered adjusted earnings per share …
Northrop Grumman's (NYSE:NOC) first-quarter 2026 results arrived at a moment when the structural backdrop for U.S. defence spending has rarely looked more consequential. The company reported $9.88 billion in revenue, a 4.4% year-on-year increase, with organic sales climbing 5%. Segment operating income crossed $1 …
3M's (NYSE:MMM) first-quarter results for 2026 present a company that is operationally improving faster than its top line would suggest. Adjusted earnings per share of $2.14 beat Wall Street forecasts by a meaningful margin, and adjusted operating margin of 23.8% expanded 30 basis points …
America's largest homebuilder delivered a second-quarter earnings beat that offered Wall Street more relief than conviction. D.R. Horton (NYSE:DHI) reported adjusted earnings per share of $2.24 for the quarter ended March 31, clearing the analyst consensus of $2.13. Revenue of $7.56 billion edged past …
Earnings Beat Masks a More Complicated Operational Picture
RTX Corporation (NYSE:RTX) opened 2026 with a financial performance that most industrial conglomerates would consider exceptional. Adjusted earnings per share of $1.78 surpassed consensus estimates by nearly 18%. Sales of $22.1 billion exceeded expectations by roughly $600 million. Management raised full year guidance on …
Capital One Financial (NYSE:COF) delivered first-quarter 2026 results that, on the surface, disappointed. Adjusted earnings per share came in at $4.42, trailing consensus. Revenue of $15.23 billion rose 52% year over year yet missed estimates by approximately $130 million. The stock slipped roughly 2% …
Danaher Corporation (NYSE:DHR) first quarter of 2026 delivered a revealing split: an earnings beat underpinned by operational discipline, alongside revenue that fell fractionally short of consensus, exposing structural pressures that remain unresolved across its diagnostics franchise.
GAAP Losses Narrow but Remain Structural
IPO Pricing Range and Valuation Sensitivity
Please wait processing your request...